Cross-sectional frequency of solicited, self-reported symptoms suggestive of myo/pericarditis at visits 2 weeks post-vaccination/boost.

atotal number of participants who received: MVA = 382; placebo = 43.bexpressed in mean ± standard deviation; for participants who had multiple reports of a given symptom, the minimum number of days post-vaccination and maximum duration of symptoms were used.cpalpitations and flu-like symptoms not collected for SLU-DMID study.n/a = not applicable.